Tempest Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tempest Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Tempest Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 26.6M shares, a 85.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 26.6M +12.2M +85.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 24.5M +11.9M +94.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 22.2M +11.7M +110% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 22M +11.5M +110% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 14.3M +3.81M +36.2% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 12.6M +2.26M +21.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 10.6M +3.39M +47.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 10.5M +3.61M +52.2% Dec 31, 2022 10-K 2024-03-19
Q3 2022 10.5M +3.62M +52.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 10.3M +3.69M +55.6% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 7.17M -11.9M -62.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 6.91M +6.38M +1211% Dec 31, 2021 10-K 2023-03-22
Q3 2021 6.9M -12.1M -63.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 6.64M -12.4M -65.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 19M +44.8K +0.24% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 527K -17.7M -97.1% Dec 31, 2020 10-Q 2021-08-12
Q3 2020 19M +5.53M +41% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 19M +5.59M +41.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 19M +5.64M +42.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 18.3M +4.91M +36.7% Dec 31, 2019 10-K 2021-03-29
Q3 2019 13.5M -22.4M -62.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 13.4M -22.4M -62.5% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 13.4M -22.4M -62.6% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 13.4M +13.1M +5322% Dec 31, 2018 10-K 2020-03-11
Q3 2018 35.8M +121K +0.34% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 35.8M +103K +0.29% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 35.8M +96.8K +0.27% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 246K -35.4M -99.3% Dec 31, 2017 10-K 2019-04-01
Q3 2017 35.7M +98.7K +0.28% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 35.7M +126K +0.36% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 35.7M +8.35M +30.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 35.6M +8.34M +30.6% Dec 31, 2016 10-K 2018-03-15
Q3 2016 35.6M +8.33M +30.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 35.6M +8.3M +30.4% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 27.3M +277K +1.03% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 27.3M +3.21M +13.3% Dec 31, 2015 10-K 2017-03-02
Q3 2015 27.3M +3.49M +14.7% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 27.3M +3.67M +15.5% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 27M +3.69M +15.8% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 24.1M +6.54M +37.3% Dec 31, 2014 10-K 2016-02-26
Q3 2014 23.8M +6.71M +39.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 23.6M +6.71M +39.7% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 23.3M +6.63M +39.7% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 17.5M +4.92M +39% Dec 31, 2013 10-K 2015-03-16
Q3 2013 17.1M +4.62M +37.1% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 16.9M +16.9M Jun 30, 2013 10-Q 2013-08-13
Q1 2013 16.7M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 12.6M +11.4M +943% Dec 31, 2012 10-K 2014-02-27
Q3 2012 12.5M Sep 30, 2012 10-Q 2012-11-13
Q2 2012 1.56K* Jun 30, 2012 10-Q 2012-08-14
Q4 2011 1.21M Dec 31, 2011 10-K 2013-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.